Abstract
In this issue, Hatoum et al1 demonstrate that patients treated with rivastigmine for 1 year in skilled nursing homes have a reduced occupational disruptiveness (OD) score on the Neuropsychiatric Inventory-Nursing Home Version (NPI-NH-OD) as compared to the initial admission score. The reduction in OD was seen across several domains of the NPI and was correlated with the dose of rivastigmine that was tolerated. These results contrast with the expected increase in OD with disease progression. This study supports the conclusion that the cholinesterase inhibitors can be effective in reduction of problematic behaviors and that the benefits of treatment extend beyond the patient to the caregivers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Medical Directors Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
